Overview

Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the outcome of intracranial germinoma treated with chemotherapy plus reduced radiotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Bleomycin
Carboplatin
Cyclophosphamide
Etoposide
Etoposide phosphate